UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proteogenomic discovery of cancer antigens: Neoantigens and beyond

Pathology international, 2019-09, Vol.69 (9), p.511-518

2019

Volltextzugriff (PDF)

HLA class II neoantigen presentation for CD4 + T cell surveillance in HLA class II-negative colorectal cancer

Oncoimmunology, 2024-12, Vol.13 (1)

2024

Volltextzugriff (PDF)

Characterization of Proteasome-Generated Spliced Peptides Detected by Mass Spectrometry

The Journal of immunology (1950), 2022-06, Vol.208 (12), p.2856-2865

2022

Volltextzugriff (PDF)

Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma

Cancer Immunology, Immunotherapy, 2022-04, Vol.71 (4), p.905-918

2022

Volltextzugriff (PDF)

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

Cancer Immunology, Immunotherapy, 2022-04, Vol.71 (4), p.795-806

2022

Volltextzugriff (PDF)

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

Cancer Immunology, Immunotherapy, 2022-04, Vol.71 (4), p.795-806

2022

Volltextzugriff (PDF)

Palladium-Induced Temporal Internalization of MHC Class I Contributes to T Cell-Mediated Antigenicity

Frontiers in immunology, 2021-12, Vol.12, p.736936-736936

2021

Volltextzugriff (PDF)

Combined chemoradiotherapy and programmed cell death‐ligand 1 blockade leads to changes in the circulating T‐cell receptor repertoire of patients with non‐small‐cell lung cancer

Cancer science, 2022-12, Vol.113 (12), p.4394-4400

2022

Volltextzugriff (PDF)

Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions

Oncoimmunology, 2021-01, Vol.10 (1), p.1870062-1870062

2021

Volltextzugriff (PDF)

Therapeutic Potential of Cancer Vaccine Based on MHC Class I Cryptic Peptides Derived from Non-Coding Regions

Immuno, 2021-12, Vol.1 (4), p.424-431

2021

Volltextzugriff (PDF)

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.2057-2065

2023

Volltextzugriff (PDF)

The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer

Cancer immunology research, 2018-03, Vol.6 (3), p.358-369

2018

Volltextzugriff (PDF)

Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition

Oncoimmunology, 2017-02, Vol.6 (2), p.e1274476-e1274476

2017

Volltextzugriff (PDF)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma

JCI insight, 2023-08, Vol.8 (16)

2023

Volltextzugriff (PDF)

835 Structural difference caused by mutated residues is correlated with immunogenicity of neoantigens and specificity of reactive T cells

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A499-A500

2020

Volltextzugriff (PDF)

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy

Cancers, 2021-12, Vol.14 (1), p.106

2021

Volltextzugriff (PDF)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue

JCI insight, 2021-07, Vol.6 (14)

2021

Volltextzugriff (PDF)

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses

Oncoimmunology, 2017-04, Vol.6 (4), p.e1293214-e1293214

2017

Volltextzugriff (PDF)

Abstract 6610: To identify neoantigens relevant to anti-tumor activity is challenging even with NGS-based prediction combined with MHC ligandome profiling

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6610-6610

2020

Volltextzugriff (PDF)

Upstream Position of Proline Defines Peptide-HLA Class I Repertoire Formation and CD8 + T Cell Responses

The Journal of immunology (1950), 2019-05, Vol.202 (10), p.2849-2855

2019

Volltextzugriff (PDF)

Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes

Science advances, 2024-09, Vol.10 (38), p.eado6491

2024

Volltextzugriff (PDF)

CD8 + T-cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1

Cancer immunology research, 2021-11, Vol.9 (11), p.1342-1353

2021

Volltextzugriff (PDF)

Microenvironmental stresses induce HLA‐E/Qa‐1 surface expression and thereby reduce CD8+ T‐cell recognition of stressed cells

European journal of immunology, 2016-04, Vol.46 (4), p.929-940

2016

Volltextzugriff (PDF)

Abstract B018: Landscape of natural HLA class I ligand peptides of cancer cells

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.B018-B018

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Immunology
(19)
Oncology
(14)
Humans
(11)
Immunotherapy
(8)
Lymphocytes T
(7)
Peptides
(7)
Antigens
(6)
Histocompatibility Antigen Hla
(6)
Mutation
(6)
Neoantigen
(6)
Animals
(5)
Cd8-Positive T-Lymphocytes - Immunology
(5)
Histocompatibility Antigens Class I - Immunology
(5)
Lymphocytes
(5)
Mice
(5)
Antigens, Neoplasm - Immunology
(4)
Cancer Research
(4)
Cell Line, Tumor
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Proteogenomic discovery of cancer antigens: Neoantigens and beyond

HLA class II neoantigen presentation for CD4 + T cell surveillance in HLA class II-negative colorectal cancer

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA‐A24‐positive pancreatic adenocarcinoma

Characterization of Proteasome-Generated Spliced Peptides Detected by Mass Spectrometry

Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

Palladium-Induced Temporal Internalization of MHC Class I Contributes to T Cell-Mediated Antigenicity

Combined chemoradiotherapy and programmed cell death‐ligand 1 blockade leads to changes in the circulating T‐cell receptor repertoire of patients with non‐small‐cell lung cancer

Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions

Therapeutic Potential of Cancer Vaccine Based on MHC Class I Cryptic Peptides Derived from Non-Coding Regions

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma

The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer

Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma

835 Structural difference caused by mutated residues is correlated with immunogenicity of neoantigens and specificity of reactive T cells

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses

Abstract 6610: To identify neoantigens relevant to anti-tumor activity is challenging even with NGS-based prediction combined with MHC ligandome profiling

Upstream Position of Proline Defines Peptide-HLA Class I Repertoire Formation and CD8 + T Cell Responses

Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes

CD8 + T-cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1

Microenvironmental stresses induce HLA‐E/Qa‐1 surface expression and thereby reduce CD8+ T‐cell recognition of stressed cells

Abstract B018: Landscape of natural HLA class I ligand peptides of cancer cells

Suchergebnisse filtern